Impact of Exercise on Overnight Glycemic Control in Children with Type 1 Diabetes (T1DM) Eva Tsalikian 1 ; Roy Beck 2 ; Peter Chase 3 ; Tim Wysocki 4 ;

Slides:



Advertisements
Similar presentations
Update on the Closed-Loop Artificial Pancreas Project
Advertisements

Diabetes in Young Women Francine R. Kaufman, M.D. Professor of Pediatrics The Keck School of Medicine of USC Head, Center for Diabetes and Endocrinology.
Advanced Pumping. Objectives: Identify situations to utilize temporary basal rate in pump therapy patients. Identify examples of when to use combination.
Down Alert Function of the GlucoWatch® G2 TM Biographer (GW2B) During Insulin- induced Hypoglycemia in Children Eva Tsalikian 1, Craig Kollman 2, Rosanna.
INTRODUCTION TO CONTINUOUS GLUCOSE MONITORS
Diabetes Self-Management Profile- Revised for Conventional and Flexible Insulin Regimens Wysocki, T. 1, Xing, D. 2, Fiallo-Scharer, R. 3, Doyle, E. 4,
Canadian Diabetes Assocaition Clinical Practice Guidelines Pharmacotherapy in Type 1 Diabetes Chapter 12 Angela McGibbon, Cindy Richardson, Cheri Hernandez,
Continuous Glucose Monitoring. Diabetes Management Evolution Insulin Delivery Glucose Monitoring 2000 First CGM system 2006 Paradigm REAL- Time, combining.
1 GLUCOWATCH ® G2™ BIOGRAPHER H. PETER CHASE, MD I)INTRODUCTION II)ACCURACY DATA III) HOME PILOT TRIAL IV) DIRECNET STUDY GROUP V) SUMMARY.
Hypoglycemia DR. Hamed Habib Consultant pediatrician.
New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia.
Diabetes Control in Youth: The American Experience Georgeanna J. Klingensmith, MD Keystone Colorado July 2008.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Reference Cooper BA, and the IDEAL study group. A randomized controlled trial of early versus late initiation of dialysis. N Engl J Med [Accessed.
Clinical Protocol Using Insulin Pump Easy Guideline for Initiating Insulin Pumps on Type 2 Diabetes Patients.
1 Progress Towards an Artificial Pancreas for T1D WILLIAM TAMBORLANE, MD Chief of Pediatric Endocrinology, Yale University, Deputy Director, Yale Center.
Suhyla Alam (Eastern Virginia Medical School), Amy West, Maura Downey, Jane EB Reusch, Kristen Nadeau University of Colorado Denver and Children’s Hospital.
Accuracy of the FreeStyle Navigator ™ Continuous Glucose Monitor Diabetes Research in Children Network Larry Fox, 1 Roy Beck, 2 Stuart Weinzimer, 3 Katrina.
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the GlucoWatch® G2 TM Biographer in the Management of Type 1 Diabetes.
By Chris Defeyter and Ashlie Sklenicka.  Type 2 diabetes is when your body doesn’t use insulin properly.  At first your pancreas makes extra insulin.
Accuracy of the A1cNow ® in Children with T1D. Diabetes Research in Children Network Larry Fox, 1 Dongyuan Xing, 2 Katrina Ruedy, 2 Roy Beck, 2 Craig Kollman,
Limitations of Statistical Measures of Error in Assessing the Accuracy of Glucose Sensors Craig Kollman1, Darrell Wilson2, Tim Wysocki3, Rosanna Fiallo-Scharer4,
INSULIN THERAPY IN TYPE 1 DIABETES
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the Feasibility of Computer-Based Data Acquisition and Transmission.
By Chris Defeyter and Ashlie Sklenicka. Type 2 Diabetes  Type 2 diabetes is when your body doesn’t use insulin properly.  At first your pancreas makes.
A 5-center CRC-based Study of the Accuracy of the GlucoWatch® G2 TM Biographer in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1, Bruce.
Inhaled Human Insulin Treatment in Patients with Type 2 Diabetes Mellitus Matthew Faiman.
Mealtime Glycemic Excursions in Pediatric Subjects with Type 1 Diabetes: Results of the Diabetes Research in Children (DirecNet) Accuracy Study Study Group.
Closed-Loop Insulin Delivery in Children
Abstract Background: As part of a study to evaluate the accuracy of the GlucoWatch ® G2 TM Biographer and the Continuous Glucose Monitoring System (CGMS.
Diabetes Control and Complications Trial (DCCT) Results indicate that most youth with T1DM should be treated intensively in order to reduce the risk of.
Background: DirecNet Diabetes Research in Children Network NIH funded collaborative study group 5 clinical centers, central laboratory, coordinating center,
Diabetes Research in Children Network Pilot Study of the Navigator TM Continuous Glucose Monitoring System in Children with Type 1 Diabetes: Safety, Tolerability,
Journal Club 埼玉医科大学 総合医療センター 内分泌・糖尿病内科 Department of Endocrinology and Diabetes, Saitama Medical Center, Saitama Medical University 松田 昌文 Matsuda, Masafumi.
Event-Based Assessments of Sensor Accuracy during Exercise-Induced Reductions in Glucose in Children with Type 1 Diabetes Craig Kollman, 1 Darrell Wilson,
Internet-based pilot study comparing low fat with high fat evening snacks in children and adolescents with Type 1 Diabetes using continuous glucose monitoring.
Use of The FreeStyle Navigator TM Continuous Glucose Monitoring System in Children on Glargine- based Multiple Daily Injection Therapy Stuart Weinzimer.
Use of the FreeStyle Navigator ™ Continuous Glucose Monitoring System in Children with Type 1 Diabetes Diabetes Research in Children Network L. A. Fox,
Lack of Effectiveness of the GlucoWatch Biographer (GW2B) in Altering Glycemic Control in Children with Type 1 Diabetes H. Peter Chase 1, Roy Beck 2, William.
A Comparison of the Original vs. Modified Continuous Glucose Monitoring System (CGMS™) Sensor During Hypoglycemia in the Diabetes Research in Children.
Basal Bolus: The Strategy for Managing All Diabetes Fall, 2003 Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
Utility of CGMS as a Measure of Glycemic Control in Children with Type 1 Diabetes (T1DM) Rosanna Fiallo-Scharer, MD for.
Glucose Control and Monitoring
Reliability of two indices of the biologic variability in glycosylation among children and adolescents with T1DM Darrell M Wilson 1, Rosanna Fiallo-Scharer.
Effectiveness of Early Intensive Therapy On β-Cell Preservation in Type 1 Diabetes Featured Article: Bruce Buckingham, M.D., Roy W. Beck, M.D., P.H.D.,
Evaluation of Factors Affecting CGMS Calibration Bruce Buckingham, 1 Craig Kollman, 2 Roy W Beck, 2 Andrea Kalajian, 2 Rosanna Fiallo-Scharer, 3 Michael.
Accuracy Study of the Medtronic Minimed Continuous Glucose Monitoring System (CGMS) and GlucoWatch® G2TM Biographer (GW2B) in Children with Type 1 Diabetes.
Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free- Living, Randomized Clinical Trial Featured Article: Roman Hovorka,
Alterations in White Matter Structure in Young Children With Type 1 Diabetes Featured Article: Naama Barnea-Goraly, Mira Raman, Paul Mazaika, Matthew Marzelli,
Type I Diabetes Mellitus
Performance of the DCA 2000 ® + Analyzer for Measurement of Hemoglobin A1 c Levels in Children with T1DM in a DirecNet Outpatient Clinical Trial.
Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes A pilot, randomized,
Achieving Glycemic Control in the Hospital Setting (Part 2 of 4)
Clarification of Pump Orders from Barbara Davis Center Diabetes Resource Nurse Winter/Spring 2013.
DirecNet Study of the Accuracy of the Navigator Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1,
The Physiological Variations of Plasma Glucose Concentrations in Healthy, Non-Diabetic Children: Use of Continuous Glucose Sensors Nelly Mauras, Roy Beck,
Special Situations In The Management Of In-Patient Hyperglycemia
Introduction Subcutaneous insulin absorption is not reproducible and insulin entry directly into the circulation is not linked to glucose sensing Basal.
Diabetic hypoglycemia from prevention to management.
Physical Activity Checklist
Diabetes and Risk of CV Outcomes
Program Goals. Inhaled Insulin: Overcoming Past Obstacles With Advances in Understanding.
Hemoglobin A1c Targets for Glycemic Controls
A: Percentage of type 1 diabetic and type 2 diabetic patients with asymptomatic hypoglycemias detected by the CGMS. B: Daily distribution of asymptomatic.
Key Insulin Side Effects*
Type 1 Diabetes: Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors.
A: Relative risk of experiencing one or more hypoglycemic events per participant at any time (24 h) and during the night (0000–0559 h) for Gla-300 vs.
Intranasal Glucagon Investigators
Fresh perspectives ON BASAL Insulins in diabetes care
in Youth With Type 1 Diabetes
Presentation transcript:

Impact of Exercise on Overnight Glycemic Control in Children with Type 1 Diabetes (T1DM) Eva Tsalikian 1 ; Roy Beck 2 ; Peter Chase 3 ; Tim Wysocki 4 ; Bruce Buckingham 5 ; Stuart Weinzimer 6 ; Nelly Mauras 4 ; Craig Kollman 2 ; Dongyuan Xing 2 ; Katrina Ruedy 2 ; William Tamborlane 6 and the Diabetes Research in Children Network (DirecNet) Study Group. 1 Iowa City, IA; 2 Tampa, FL; 3 Denver, CO; 4 Jacksonville, FL; 5 Stanford, CA; 6 New Haven, CT

Hypoglycemia in children with T1DM Studies in children and adults have demonstrated that the majority of severe hypoglycemic events occur at night and suggest that such events are more frequent following days of increased physical activity

Nocturnal hypoglycemia in children with T1DM Limited data are available regarding the role of afternoon exercise on overnight severe hypoglycemic events in children with T1DM And No studies to date have examined the impact of exercise on asymptomatic, biochemical hypoglycemia during the overnight period using rigorously controlled research protocols.

The Diabetes Research in Children Network (DirecNet) is a multi-center study group whose objectives include the examination of factors that contribute to the risk of hypoglycemia and the development of strategies to prevent this complication of treatment of children with T1DM.

Aim of present study To examine the effect of late afternoon exercise that simulates common after- school sports activities on the frequency of overnight hypoglycemia. We hypothesized that such exercise would significantly increase the risk of nocturnal hypoglycemia compared to a sedentary day without afternoon exercise.

Study subjects (n=50) Female 44% Caucasian 90% Age (yrs: mean + SD) 15 ± 2 Duration T1DM (yrs: mean + SD) 7 ± 4 Pump 54% MDI 46% HbA1c (mean + SD) 7.8 ± 0.8%

Study procedures 2 CRC admissions 1-4 weeks apart Conditions: –Same meals and basal and bolus insulin doses based on home regimen for sedentary day –Exercise or rest between 4-6PM Glucose measurements –Q 15 min during exercise –Q 60 min from 6 PM to 10 PM –Q 30 min from 10 PM to 6 AM Primary outcome: –Glucose level < 60 mg/dL

Exercise protocol TIME (minutes) Exercise Exercise Five minute rest periods Exercise at 60% maximum effort (VO2max): Heart rate 140 beats/minute All subjects achieved target heart rate for all cycles except for one subject that missed target for one cycle only Treadmill

Glucose lowering effect of exercise

Sedentary Exercise Mean glucose levels on the two study days Exercise Period 4:00 – 5:15 PM

Percentage of patients experiencing nocturnal hypoglycemia (<60mg/dL) on exercise and sedentary nights 46% 26% 6% 22% Exercise night only Neither night Both nights Sedentary night only

Nocturnal hypoglycemia by glucose level at bedtime 2/28=7% 8/22=36% 16/28=57% 12/22=55% Bedtime Glucose

Summary 63% of subjects with pre-exercise glucose of < 130 mg/dL became hypoglycemic during exercise Lower mean blood glucose levels were observed throughout the night following a 60-minute period of moderate aerobic exercise, in the afternoon, in children with T1DM. Afternoon exercise increased the risk of nocturnal hypoglycemia from 28% to 48% when food intake and insulin regimens were not altered. On sedentary but not exercise days, nocturnal hypoglycemia was rarely observed when the 9 PM glucose was >130 mg/dL.

Conclusion Our findings support the importance of modifying the child ’ s diabetes treatment regimen following afternoon exercise in order to reduce the risk of hypoglycemia.

Barbara Davis Center –H. Peter Chase –Rosanna Fiallo-Scharer –Jennifer Fisher –Barbara Tallant University of Iowa –Eva Tsalikian –Michael Tansey –Linda Larson –Julie Coffey Nemours Children’s Clinic –Tim Wysocki –Nelly Mauras –Larry Fox –Keisha Bird –Kelly Lofton Stanford University –Bruce Buckingham –Darrell Wilson –Jennifer Block –Paula Clinton Yale University –William Tamborlane –Stuart Weinzimer –Elizabeth Doyle –Kristen Sikes –Amy Steffen Jaeb Center for Health Research –Roy Beck –Katrina Ruedy –Craig Kollman –Dongyuan Xing –Cynthia Stockdale